Efficacy of rabdosia rubescens in the treatment of gingivitis

Abstract

This study evaluated the efficacy of rabdosia rubescens against gingivitis and compared the therapeutic efficacy of different dosage forms of rabdosia rubescens. A multi-center, randomized, double-blind, double-simulation, positive-controlled and parallel trial was conducted. A total of 136 patients exhibiting clinical symptoms of gingivitis were enrolled. The subjects were randomly assigned to two groups: test group (n=67), in which rabdosia rubescens drop pill (960 mg) and 4 tablets of simulation agent of rabdosia rubescen were orally given to the subjects three times a day for 5 days; and control group (n=69), in which the subjects were administered the tablets of rabdosia rubescens (1000 mg) and 24 drop pills of simulation agent of rabdosia rubescens thrice daily for 5 days. The experimental protocols and diagnostic criteria were established by expert panel prior to the experiment. The clinical symptoms were graded according to the severity of the disease and quantified. The total scores and scores for each clinical symptom of gingivitis were assessed at baseline and on the 6th day post-treatment. The therapeutic efficacy was compared between the two groups and in each group itself before and after the treatment. The results showed that in the two groups, the subjects who were given rabdosia rubescens, drop pill or tablet, had a decrease in total scores and scores for each clinical symptom when compared with those before treatment (P<0.01). There was significant difference in the therapeutic efficacy between the test group and the control group with the efficacy rate being 92.54% and 79.71% respectively (P<0.05). It was concluded that rabdosia rubescens showed great promise in treating gingivitis. And rabdosia rubescens drop pill was more efficacious than rabdosia rubescens tablet.

Keywords

rabdosia rubescens / drop pill / tablet / gingivitis

References

[1] Li Q, Chen Z, Liu J, et al. Effect of oridonin on the hemodynamics in anaesthetized rabbits. Chin Pharm Bull (Chinese), 1993(1):53–55

[2] LiQ., LiuJ., ChenZ., et al.. Effect of oridonin on the hemodynamics in rabbits and its mechanism research. J Norman Bethune Univ Med Sci (Chinese), 1994, 20(2): 128-129

[3] SuX.H., DongC.M., WangW.L., et al.. Dy namics research of main secondary metabolites accumulation in rabdosia rubescens tissue culture. Zhongguo Zhong Yao Za Zhi (Chinese), 2008, 33(9): 1080-1084

[4] FengN., WuP., LiQ., et al.. Oridonin-loaded poly(epsilon-caprolactone)-poly (ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. J Drug Target, 2008, 16(6): 479-485

[5] IkezoeI., ChenS.S., TongX.J., et al.. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cell. Int J Oncol, 2003, 23(4): 1187-1193

[6] ChengY., QiuF., YeY.C., et al.. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J, 2009, 276(5): 1291-1306

[7] LiD., WuL.J., TashiroS., et al.. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway. J Asian Nat Prod Res, 2008, 10(1–2): 77-87

[8] WangY.F., JiangJ.H., WangQ.R., et al.. Antitumor and immunological activities of polysaccharides from rabdosia rubescens. Chin J Pathophysiol (Chinese), 2002, 18(11): 1341-1343

[9] LiuY.Q., YouS., TashiroS., et al.. Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells. Int Immunopharmacol, 2006, 6(2): 260-268

[10] LiuY.Q., YouS., TashiroS., et al.. Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells. J Pharmacol Sci, 2005, 98(4): 361-371

[11] ZhangY., WangY.. Effect of rebescensine A on removal of active free radicals. Henan Med Res (Chinese), 1998, 8(2): 100-104

[12] XuX., ZhangX.L.. Study of Oridonin on antioxidation. J Strait Pharm (Chinese), 2002, 16(6): 28-31

[13] SagarS.M., YanceD., WonqR.K.. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol, 2006, 13(1): 14-26

[14] AdamsL.S., SeeramN.P., HardyM.L., et al.. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med, 2006, 3(1): 117-124

[15] ZhouG.B., KangH., WangL., et al.. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood, 2007, 109(8): 3441-3450

[16] YuY.N., YuY.X.. One case-therapy of acute pharyngitis with Rabdosia rubescens. Chin Remed Clin (Chinese), 2002, 2(3): l71

[17] FengZ.Y., ZhangF.L., TianX.J.. Observation for therapeutic effect of compound rabdosia rubescens toroche on cute pharyngitis and cute pharyngitis. J Youjiang Med (Chinese), 2006, 34(6): 599-601

[18] CaoC.F.Periodontics, 20052Beijing, People’s Medical Publishing House: 75-107

[19] ZhuangZ.Y.Oral Science, 20046Beijing, People’s Medical Publishing House: 54-72

[20] LiQ., FengW.S.. The latest development of researches on the chemical constituents and pharmacological activity of rabdosia rubescens hara. J Henan Univ Chin Med (Chinese), 2003, 18(6): 31-33

[21] DaiH., LiuS.H., ZhouX., et al.. Research progress of pharmacological actions and clinical application of rabdosia rubescens. Sichuan J Physiol Sci (Chinese), 2008, 30(1): 20-21

[22] HuaH.Y., ZhuJ.L., YeQ.X.. Experimental research on bacteriostatic effect of rabdosia rubescens drop pill and table in vitro and in vivo. Chin Trad Herb Drug (Chinese), 2006, 37(Suppl): 79-81

[23] SongF.J., WuS.J., LiangJ.J.. Study on antibacterial activity about isodon rubescens from badong. J South-Central Univ Natl (Natural Science Edition) (Chinese), 2004, 23(4): 9-11

[24] DuanX.Y., WangY.H.. Experimental research on bacteriostatic effect of compound rabdosia rubescens toroche in vitro. J Henan col Trad Chin Med (Chinese), 1997, 12(6): 38-39

[25] XuZ.K.. Rabdosia rubescens expected to be the second taxol. Modern Chin Med (Chinese), 2007, 9(8): 43-45